ZOLL’s donation of the National AED Registry ™ to the Emergency AED Registry, hosted by PulsePoint, optimizes dispatch and citizen responder accessibility to AED locations. ZOLL Unveils Remote View on ...

LOWELL, Mass., Jan. 6, 2011 /PRNewswire/ -- Saints Medical Center, a leading non-profit healthcare facility in the Greater Lowell area, is pleased to announce it has entered into a multi-faceted ...

On March 10, 2023, ZOLL Medical Corporation (“ZOLL”) filed a notice of data breach with the Maine Attorney General following a cybersecurity incident that resulted in the confidential information of ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has received FDA 510(k) ...

ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR), a medical device and digital ...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today it has entered into an agreement to license Inovise Medical, Inc.’s ambulatory AUDICOR ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and CAIRE, Inc., a leading oxygen supply ...

EMS revenue integrity depends on the very first moments of the call. The data dispatchers collect doesn’t just guide the ...

July 9, 2020—CHELMSFORD, MA —ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced today that it has launched its new ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® ...

CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has successfully ...

A phase 3 trial of Zoll Medical’s LifeVest has missed its primary endpoint. The study found that people who started using the wearable defibrillator the week after they had a heart attack were as ...